Philadelphia high school students get job training and opportunities at Jefferson Health
The joint venture from Jefferson, the School District of Philadelphia and Esperanza College is providing some much-needed job training and opportunities.
Aleycha Peralta, who's now a student at Esperanza College, was part of the Jefferson Workforce Development Program. She says it was life-changing.
"I thought it was the opportunity of a lifetime," said Peralta, who wants to become a doctor.
The program provides free training to Philadelphia high school students, who can then apply for jobs at Jefferson Health.
"The mission of this program is to provide talent streams for entry-level workforce in the technical space, whether it's a patient care tech, medical assistant, surgical tech," said Theresa Fortner, who oversees the workforce program.
The program helps fill jobs in the Jefferson system and benefits the community.
"These are students that represent undeserved communities, and securing a full-time job here at Jefferson helps stabilize them economically and helps support their families," Fortner said.
The students in the program get 1,000 hours of classroom instruction and hands-on training.
Batoul Ayyash said that through the program, she's decided to become a nurse.
"Our main focus is the patient, so we take care of the patient, we bathe them, we talk to them, we listen to them," Ayyash said. "This allows us to understand the root of health care before we actually go into the medicine."
So far, 38 students have completed the workforce program, including many who now work at Jefferson.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
AMD to report Q2 earnings as Wall Street looks to AI, PC sales growth
AMD (AMD) will report its second quarter results after the bell on Thursday, giving Wall Street a better understanding of the AI chip market ahead of rival Nvidia's (NVDA) report later this month. The company stands to benefit from the resumption of its chip sales in China after the Trump administration briefly banned them in April, as well as the potential for pull-forward in CPU sales as manufacturers built up inventory to fend off the impact of tariffs on PC sales. AMD shares are up 47% year to date and 34% over the last 12 months, while Nvidia shares are up 33% and 66%, respectively. For the quarter, AMD is expected to see adjusted earnings per share (EPS) of $0.49 on revenue of $7.4 billion, according to Bloomberg consensus estimates. That would represent a 29% decline in EPS but a 27% jump in revenue. Part of the reason for that is that AMD is expected to take a $700 million hit from the Trump administration's ban on the sale of the company's MI308 AI chips for China. That's far lower than the $4.5 billion write-down Nvidia took in Q1 and the $8 billion it said it would take in Q2 due to the impact of the ban on its own China-specific chip. Trump reversed course on the ban last month, which should help make up for some of those losses in the coming quarters. AMD should also benefit from the launch of its MI350 line of AI chips, designed to go toe-to-toe with Nvidia's Blackwell-powered chips. According to AMD, the MI350 line, which includes the MI350X and MI355X, offers four times the AI compute performance and a 35x increase in inferencing capabilities versus its predecessors. 'We expect AMD to post higher results and higher guidance, as we see improving traditional server demand and latest generation share gains, as well as strong demand for MI355,' KeyBanc Capital Markets analyst John Vinh wrote in an investor note ahead of the company's earnings. AMD's Data Center segment is expected to bring in $3.2 billion in the quarter, up 14% year over year from Q2 2024 when the business generated $2.8 billion. Beyond the Data Center segment, AMD's Client business, which includes sales of CPUs for desktops and laptops, is expected to see $2.5 billion. That's a massive 71% jump versus the $1.4 billion it brought in during the same quarter last year. That anticipated increase is thanks to the anticipated pull-forward in laptop and desktop shipments to combat the Trump administration's tariffs. But it will also hurt sales in the back half of the year. 'Similar to [Intel], we expect AMD Client to benefit from tariff-related pull-in of demand in Q2, and that same benefit to likely reverse in 2H, leading to below-seasonal Q3/Q4,' BofA Global Research analyst Vivek Arya wrote in an investor note. 'For [Intel], new Street estimates for [Client Computer Group] now point to +4%/+2% [quarter-over-quarter growth] in Q3/Q4, below +7%/+4% prior to Q2 earnings and also below typical +9%/+4%,' Arya added. 'However, for AMD, we highlight Street estimates already embed the demand normalization, with Client estimates of +2%/+0% in Q3/Q4 well below typical +15%/+14%.' Email Daniel Howley at dhowley@ Follow him on X/Twitter at @DanielHowley. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 minutes ago
- Yahoo
Tyson Foods hasn't seen 'material' impact from Trump tariffs as consumer protein push lifts results
Tyson Foods (TSN) reported results Monday that were better than expected for its fiscal third quarter. A consumer focus on protein and a lack of immediate impact from President Trump's tariff policies boosted results. "Consumers are prioritizing protein ... over other foods, but they're also prioritizing food as essential versus the non-essential things like apparel, ... bigger ticket items," Tyson Foods CEO Donnie King said. As far as the impact of President Trump's tariffs, King said, "I would not call anything we've seen from tariffs today, not only beef, but in pork, chicken. I don't see a material impact from that at this point." In the quarter, Tyson reported sales grew 4% to $13.88 billion, topping forecasts for revenue to tally $13.55 billion, according to Bloomberg data. Adjusted earnings per share were $0.91 in the quarter, ahead of forecasts for $0.78. The company also said its sales for its fiscal year 2025, which wraps up during the current quarter, will rise 2% to 3% from last year, better than its previous outlook for sales to be flat to up 1%. Tyson Foods stock rose about 3% following the results on Monday. Year to date, the stock remains down over 5%, trailing the S&P 500's roughly 7.5% gain. Read more: Live coverage of corporate earnings Chicken was the company's strongest category during the quarter, with volumes rising 2.4% alongside an average price increase of 1.1%. Consumers leaned into frozen items like Tyson Simple Ingredient nuggets, which have higher protein. Tyson's fresh chicken business grew volume by 2.3%. Tyson now expects its chicken segment to post operating income of $1.3 billion to $1.4 billion for the year, up from the previously expected range of $1 billion to $1.3 billion. "Our chicken business is obviously running a lot better than it has," King said. "This has been a multiyear journey, but it's running more efficiently." King said the company is also seeing the benefit from the closure of four chicken plants two years ago. Its pork business is having a moment too. Volume for that segment grew 1.5% against forecasts for a 2.3% decline. Pork delivered its strongest third quarter adjusted operating income for the company in four years. All the momentum offset a more challenging quarter for its beef business. The average price for beef increased 10%, higher than the 7.3% jump expected. Volumes declined 3.1%, more than the 2% expected, as the tightened cattle supply made fewer available for Tyson to buy and drove costs higher. Still, King said its beef consumer "has been very resilient" in the face of higher prices. For ranchers, higher beef prices have been good news, according to Texas A&M professor David Anderson, as these prices reverse the situation "for ranchers who have dealt with low prices, high costs, and drought in recent years." Fewer imports from Mexico have hit the US cattle supply, however, creating another challenge for Tyson. "I expect the tariff and retaliatory tariffs from China have introduced more struggles in [the ranchers'] business," Anderson said. "I should say it's not just high prices but fewer cattle that make it hard to get enough cattle to operate." Brooke DiPalma is a senior reporter for Yahoo Finance. Follow her on X at @BrookeDiPalma or email her at bdipalma@ Sign in to access your portfolio
Yahoo
4 minutes ago
- Yahoo
RPMG Welcomes Dr. James Weinberger and Launches Center for Male Fertility
LOS ANGELES, August 04, 2025--(BUSINESS WIRE)--Reproductive Partners Medical Group (RPMG), trusted leader in advanced fertility care and member of the Ivy Fertility network, is proud to announce the September 2025 launch of its new Center for Male Fertility, led by fellowship-trained reproductive urologist Dr. James Weinberger. As the Center's Director, Dr. Weinberger brings deep expertise in male reproductive health and a commitment to providing men with the same high level of care and clarity that RPMG is known for. "Fertility is a shared journey, and male fertility deserves just as much care and attention," said Dr. Weinberger. "Our goal is to offer answers and options in a space that's supportive, cutting-edge and designed specifically for men." Built to meet a growing need in reproductive medicine, the Center for Male Fertility provides men with a dedicated, compassionate space to understand and optimize their reproductive health. Services will include semen analysis, hormone evaluation and optimization, microsurgical sperm retrieval (mTESE), varicocelectomy, vasectomy reversal, and consultative support for couples undergoing IVF or ICSI. As one of just 2% of urologists in the U.S. fellowship-trained in male infertility microsurgery, Dr. Weinberger brings a level of precision and expertise that directly impacts outcomes. His advanced training ensures that men at RPMG receive care that goes beyond the standard. "Men are ready to be part of the fertility conversation. They just need a place to start," said Christina Westbrook, COO/CNO of RPMG. "This Center is about access and shifting how we support the full family-building journey." Referrals are now being accepted, and patients can schedule a consultation at About Reproductive Partners Medical Group With over 30 years of experience, Reproductive Partners Medical Group (RPMG) is known for delivering evidence-based fertility care. As part of the Ivy Fertility network, a globally respected leader in reproductive medicine, RPMG offers advanced treatments including IVF, IUI, third-party reproduction, and fertility preservation. The practice proudly serves all individuals and families, providing inclusive, expert care regardless of marital status, gender identity, or sexual orientation. About Ivy Fertility Ivy Fertility is globally recognized as pioneers and innovators in the field of advanced reproductive technologies, in-vitro fertilization, third-party reproduction, andrology, and fertility research. The Ivy Fertility network includes Dallas IVF, Fertility Associates of Memphis, Fertility Centers of Orange County, Idaho Fertility Center, IVF Fertility Center, Los Angeles Reproductive Center, Nevada Center for Reproductive Medicine, Nevada Fertility Center, Northern California Fertility Medical Center, NOVA IVF, Pacific Northwest Fertility, Reproductive Partners Medical Group, San Diego Fertility Center, Utah Fertility Center, and Virginia Fertility & IVF. By developing new procedures, achieving scientific breakthroughs, and teaching the latest techniques, Ivy Fertility upholds its commitment to successful outcomes and continually contributes to the development of the entire fertility community. The Ivy team is passionate about its family-building mission and works tirelessly each day to help patients become parents. View source version on Contacts Sara Zuboff, MBA, Marketing ManagerReproductive Partners Medical Groupszuboff@ | (310) 855-2229
